Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-04-01 Erlander Mark Chief Scientific Officer Exercise or conversion +1,250 4,419
2019-04-01 Erlander Mark Chief Scientific Officer Shares withheld for taxes −459 3,960
2019-04-01 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,250 4,271
2019-01-02 Erlander Mark Chief Scientific Officer Exercise or conversion +1,563 19,708
2019-01-02 Erlander Mark Chief Scientific Officer Shares withheld for taxes −698 19,010
2019-01-02 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,563 33,125
2019-01-01 Erlander Mark Chief Scientific Officer Exercise or conversion +7,500 21,180
2019-01-01 Erlander Mark Chief Scientific Officer Shares withheld for taxes −3,035 18,145
2019-01-01 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −7,500 34,688
2018-10-01 Erlander Mark Chief Scientific Officer Exercise or conversion +7,500 16,411
2018-10-01 Erlander Mark Chief Scientific Officer Shares withheld for taxes −2,731 13,680
2018-10-01 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −7,500 42,188
2018-07-24 Erlander Mark Chief Scientific Officer Grant or award · Restricted Stock Units +45,000 49,688
2018-06-20 Markin Rodney S Director Purchase +41,200 $0.85 $35K 43,085
2018-06-20 Markin Rodney S Director Purchase +41,200 $0.85 $35K 63,810
2018-06-08 Tennant Stanley Director Purchase +10,000 $0.80 $8K 28,839
2018-06-08 BRANCACCIO JOHN P Director Purchase +10,000 $0.80 $8K 13,598
2018-06-08 BRANCACCIO JOHN P Director Purchase +10,000 $0.80 $8K 53,167
2018-06-08 Tennant Stanley Director Purchase +10,000 $0.80 $8K 236,061
2018-01-30 Erlander Mark Chief Scientific Officer Exercise or conversion +90,000 147,297

Page 10 of 15 · 299 trades